|
16
|
99
|
6ptpA |
Joint x-ray/neutron structure of hiv-1 protease triple mutant (v32i,i47v,v82i) with tetrahedral intermediate mimic kvs-1 |
|
17
|
99
|
6pu8A |
Room temperature x-ray structure of hiv-1 protease triple mutant (v32i,i47v,v82i) with tetrahedral intermediate of keto-darunavir |
|
15
|
99
|
6p9aA |
Hiv-1 protease multiple mutant prs5b with darunavir |
|
19
|
99
|
6p9bA |
Hiv-1 protease multiple drug resistant mutant prs5b with amprenavir |
|
8
|
99
|
1bveA |
Hiv-1 protease-dmp323 complex in solution, nmr, 28 structures |
|
0
|
4
|
3doxP |
X-ray structure of hiv-1 protease in situ product complex |
|
0
|
4
|
1hteC |
X-ray crystallographic studies of a series of penicillin-derived asymmetric inhibitors of hiv-1 protease |
|
17
|
99
|
6dilA |
Hiv-1 protease with single mutation l76v in complex with tipranavir |
|
19
|
99
|
6dj1A |
Wild-type hiv-1 protease in complex with lopinavir |
|
17
|
99
|
6dj2A |
Hiv-1 protease with single mutation l76v in complex with lopinavir |
|
18
|
99
|
6difA |
Wild-type hiv-1 protease in complex with tipranavir |
|
16
|
99
|
6dj7A |
Hiv-1 protease with mutation l76v in complex with grl-5010 (gem-difluoro-bis-tetrahydrofuran as p2 ligand) |
|
17
|
99
|
6dj5A |
Hiv-1 protease with mutation l76v in complex with grl-0519 (tris-tetrahydrofuran as p2 ligand) |
|
18
|
99
|
6o48A |
Wild-type hiv-1 protease in complex with a substrate analog ca-p2 |
|
18
|
99
|
6o54X |
Crystal structure of multi-drug resistant hiv-1 protease pr-s17 (d25n) |
|
16
|
99
|
6o57A |
Crystal structure of multi-drug resistant hiv-1 protease pr-s17 with a substrate analog p2-nc in p41 |
|
17
|
99
|
6o5aA |
Crystal structure of multi-drug resistant hiv-1 protease pr-s17 with a substrate analog p2-nc in p61 |
|
16
|
99
|
5hvpA |
Crystallographic analysis of a complex between human immunodeficiency virus type 1 protease and acetyl-pepstatin at 2.0-angstroms resolution |
|
14
|
99
|
7upjA |
Hiv-1 protease/u101935 complex |
|
17
|
99
|
9hvpA |
Design, activity and 2.8 angstroms crystal structure of a c2 symmetric inhibitor complexed to hiv-1 protease |
|
12
|
99
|
8hvpA |
Structure at 2.5-angstroms resolution of chemically synthesized human immunodeficiency virus type 1 protease complexed with a hydroxyethylene*-based inhibitor |
|
14
|
99
|
7hvpA |
X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor |
|
18
|
99
|
6b3fA |
Crystal structure of hiv protease complexed with n-(3-fluoro-2-(2-((2s,5s)-5-methyl-1-(phenylsulfonyl)piperazin-2-yl)ethyl)phenyl)-3,3-bis(4-fluorophenyl)propanamide |
|
18
|
99
|
6b3hA |
Crystal structure of hiv protease complexed with n-(2-(2-((6r,9s)-2,2-dioxido-2-thia-1,7-diazabicyclo[4.3.1]decan-9-yl)ethyl)-3-fluorophenyl)-3,3-bis(4-fluorophenyl)propanamide |
|
16
|
99
|
6b3cA |
Crystal structure of hiv protease complexed with n-(3-fluoro-2-(2-((2s,6r)-6-methyl-1-(phenylsulfonyl)piperazin-2-yl)ethyl)phenyl)-3,3-bis(4-fluorophenyl)propanamide |
|
18
|
99
|
6b36A |
Crystal structure of hiv protease complexed with (s)-n-(3-fluoro-2-(2-(1-(phenylsulfonyl)piperazin-2-yl)ethyl)phenyl)-3,3-bis(4-fluorophenyl)propanamide |
|
16
|
99
|
6b38A |
Crystal structure of hiv protease complexed with n-(3-fluoro-2-(2-((2s,6r)-6-methyl-1-(phenylsulfonyl)piperazin-2-yl)ethyl)phenyl)-3,3-bis(4-fluorophenyl)propanamide |
|
17
|
99
|
6b3gA |
Crystal structure of hiv protease complexed with n-(3-fluoro-2-(2-((2s,6s)-6-methyl-1-(phenylsulfonyl)piperazin-2-yl)ethyl)phenyl)-3,3-bis(4-fluorophenyl)propanamide |
|
17
|
99
|
5yokA |
Structure of hiv-1 protease in complex with inhibitor kni-1657 |
|
17
|
99
|
4eyrA |
Crystal structure of multidrug-resistant clinical isolate 769 hiv-1 protease in complex with ritonavir |
|
17
|
99
|
4faeA |
Substrate p2/nc in complex with a human immunodeficiency virus type 1 protease variant |
|
17
|
99
|
4fafA |
Substrate ca/p2 in complex with a human immunodeficiency virus type 1 protease variant |
|
16
|
99
|
3uf3A |
Crystal structure of multidrug resistant hiv-1 protease clinical isolate pr20 |
|
19
|
99
|
3ufnA |
Crystal structure of multidrug resistant hiv-1 protease clinical isolate pr20 in complex with saquinavir |
|
16
|
99
|
3u71A |
Crystal structure analysis of south african wild type hiv-1 subtype c protease |
|
18
|
99
|
3ttpA |
Structure of multiresistant hiv-1 protease in complex with darunavir |
|
18
|
99
|
3t3cA |
Structure of hiv pr resistant patient derived mutant (comprising 22 mutations) in complex with drv |
|
14
|
99
|
3t11A |
Dimeric inhibitor of hiv-1 protease. |
|
19
|
99
|
3spkA |
Tipranavir in complex with a human immunodeficiency virus type 1 protease variant |
|
15
|
99
|
3so9A |
Darunavir in complex with a human immunodeficiency virus type 1 protease variant |
|
15
|
99
|
5w5wA |
Hiv protease (pr) in open form with mg2+ in active site and hive-9 in eye site |
|
17
|
99
|
5veaA |
Hiv protease (pr) with tl-3 in active site and 4-methylbenzene-1,2-diamine in exosite |
|
18
|
99
|
5e5kA |
Joint x-ray/neutron structure of hiv-1 protease triple mutant (v32i,i47v,v82i) with darunavir at ph 4.3 |
|
17
|
99
|
4yobA |
Crystal structure of apo hiv-1 protease mdr769 l33f |
|
16
|
99
|
4yoaA |
Crsystal structure hiv-1 protease mdr769 l33f complexed with darunavir |
|
17
|
99
|
5cooA |
X-ray crystal structure of wild type hiv-1 protease in complex with grl-085 |
|
19
|
99
|
5copA |
X-ray crystal structure of wild type hiv-1 protease in complex with grl-097 |
|
18
|
99
|
5conA |
X-ray crystal structure of wild type hiv-1 protease in complex with grl-015 |
|
19
|
99
|
5cokA |
X-ray crystal structure of wild type hiv-1 protease in complex with grl-0476 |
|
19
|
99
|
4u8wA |
Hiv-1 wild type protease with grl-050-10a (a gem-difluoro-bis-tetrahydrofuran as p2-ligand) |
